X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3102) 3102
Publication (497) 497
Book Review (27) 27
Book Chapter (21) 21
Government Document (4) 4
Conference Proceeding (3) 3
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2012) 2012
c-abl (1624) 1624
animals (1352) 1352
index medicus (1029) 1029
biochemistry & molecular biology (1008) 1008
proto-oncogene proteins c-abl - metabolism (951) 951
mice (877) 877
phosphorylation (842) 842
cell biology (792) 792
oncology (705) 705
tyrosine kinase (590) 590
proto-oncogene proteins c-abl - genetics (524) 524
chronic myelogenous leukemia (462) 462
dna-damage (445) 445
apoptosis (442) 442
imatinib mesylate (440) 440
signal transduction (412) 412
cell line (382) 382
molecular sequence data (382) 382
female (371) 371
bcr-abl (368) 368
activation (359) 359
chronic myeloid-leukemia (355) 355
male (351) 351
benzamides (327) 327
hematology (326) 326
pyrimidines - pharmacology (323) 323
protein binding (321) 321
amino acid sequence (317) 317
proteins (315) 315
cancer (312) 312
proto-oncogene proteins c-abl - antagonists & inhibitors (312) 312
research (305) 305
cell line, tumor (286) 286
hemic and lymphatic diseases (283) 283
protein (282) 282
genetics & heredity (279) 279
mutation (272) 272
leukemia, myelogenous, chronic, bcr-abl positive - genetics (269) 269
protein-tyrosine kinases - metabolism (268) 268
p53 (266) 266
expression (263) 263
tyrosine (258) 258
piperazines - pharmacology (254) 254
abl tyrosine kinase (248) 248
dna damage (247) 247
dna-binding proteins - metabolism (239) 239
fusion proteins, bcr-abl - genetics (236) 236
protein kinase inhibitors - pharmacology (229) 229
article (228) 228
leukemia (227) 227
cells (226) 226
cells, cultured (224) 224
philadelphia-chromosome (214) 214
transfection (213) 213
binding sites (212) 212
kinase c-abl (211) 211
proto-oncogene proteins c-abl - chemistry (210) 210
imatinib (208) 208
nuclear proteins - metabolism (207) 207
base sequence (206) 206
tumor protein p73 (205) 205
tumor suppressor proteins (205) 205
tumor cells, cultured (202) 202
antineoplastic agents - pharmacology (201) 201
binding (193) 193
kinases (193) 193
analysis (188) 188
apoptotic response (183) 183
multidisciplinary sciences (183) 183
gene (178) 178
adult (177) 177
p73 (177) 177
physiological aspects (175) 175
dna-binding proteins - genetics (173) 173
models, molecular (172) 172
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (171) 171
tyrosine - metabolism (168) 168
middle aged (167) 167
apoptosis - drug effects (165) 165
genetic aspects (165) 165
protein structure, tertiary (164) 164
tumor suppressor protein p53 - metabolism (163) 163
fusion proteins, bcr-abl - metabolism (161) 161
proto-oncogene proteins c-abl - physiology (160) 160
neoplasms (157) 157
gene expression (155) 155
src homology domains (155) 155
ionizing-radiation (151) 151
nuclear proteins - genetics (150) 150
enzyme activation (149) 149
biophysics (141) 141
abl (140) 140
genes, tumor suppressor (140) 140
proto-oncogene proteins - genetics (140) 140
leukemia, myelogenous, chronic, bcr-abl positive - pathology (139) 139
cell cycle (138) 138
chronic myeloid leukemia (138) 138
protein-tyrosine kinases - genetics (135) 135
pyrimidines - therapeutic use (132) 132
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3036) 3036
Chinese (51) 51
Japanese (14) 14
French (6) 6
German (6) 6
Spanish (4) 4
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Toxicological Sciences, ISSN 1096-6080, 2018, Volume 165, Issue 1, pp. 232 - 243
Journal Article
Cell, ISSN 0092-8674, 02/2010, Volume 140, Issue 4, pp. 517 - 528
Despite its toxicity, H O is produced as a signaling molecule that oxidizes critical cysteine residues of effectors such as protein tyrosine phosphatases in... 
PROTEINS | SIGNALING | NADPH OXIDASE | REACTIVE OXYGEN | TYROSINE PHOSPHORYLATION | C-ABL | REDOX REGULATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GROWTH-FACTORS | LIPID RAFTS | CYSTEINE-SULFINIC ACID | HYDROGEN-PEROXIDE | MAMMALIAN PEROXIREDOXIN | CELL BIOLOGY
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 09/2018, Volume 61, Issue 18, pp. 8120 - 8135
Chronic myelogenous leukemia (CML) arises from the constitutive activity of the BCR-ABL1 oncoprotein. Tyrosine kinase inhibitors (TKIs) that target the... 
CHEMISTRY, MEDICINAL | MANAGEMENT | C-ABL | BCR-ABL | DRUG DISCOVERY | IMATINIB | RESISTANCE | BINDING-SITE | PATCH-CLAMP | CHRONIC MYELOID-LEUKEMIA
Journal Article
CANCER RESEARCH, ISSN 0008-5472, 11/2016, Volume 76, Issue 22, pp. 6577 - 6587
Existing anticancer strategies focused on disrupting integrin functions in tumor cells or tumor-involved endothelial cells have met limited success. An... 
MIGRATION | INVASION | ACTIVATION | C-ABL | ONCOLOGY | STABILITY | GROWTH | PHENOTYPE | YAP | CELL | CARCINOMA
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 02/2019, Volume 139, Issue 2, pp. 439 - 447
Tyrosine kinase inhibitors have emerged as a therapeutic option for rheumatic diseases such as systemic sclerosis (SSc). Because tyrosine kinases like c-Abl... 
FIBROSIS | C-ABL | TRANSPORTERS | SENSITIVITY | TYROSINE KINASES | MECHANISMS | GROWTH-FACTOR | SKIN | EXPRESSION | CELLULAR UPTAKE | DERMATOLOGY
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 11/2014, Volume 92, Issue 2, pp. 235 - 250
Imatinib mesylate is a tyrosine kinase inhibitor with selectivity for abelson tyrosine-protein kinase 1 (c-Abl), breakpoint cluster region (Bcr)-Abl fusion... 
p27 KIP1 | pRb | Imatinib | CDK2 | c-Abl | Neuroblastoma
Journal Article
HUMAN MOLECULAR GENETICS, ISSN 0964-6906, 08/2013, Volume 22, Issue 16, pp. 3315 - 3328
Parkinsons disease is a movement disorder characterized by death of dopaminergic substantia nigra (SN) neurons and brain accumulation of -synuclein. The... 
CHRONIC MYELOGENOUS LEUKEMIA | MULTIPLE SYSTEM ATROPHY | TAU PHOSPHORYLATION | C-ABL | ABL TYROSINE KINASE | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | NITRATED ALPHA-SYNUCLEIN | GENE-TRANSFER MODEL | LEWY BODIES | NEURODEGENERATIVE DISEASES
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 01/2016, Volume 55, Issue 2, pp. 807 - 810
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 11/2004, Volume 114, Issue 9, pp. 1308 - 1316
Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic disease of the lungs with unclear etiology. Prior efforts to treat idiopathic pulmonary... 
PATHOGENESIS | MEDICINE, RESEARCH & EXPERIMENTAL | GROWTH-FACTOR-BETA | THERAPY | C-ABL | TYROSINE KINASE | FAMILY KINASES | MICE | GENE-TRANSFER | IDIOPATHIC PULMONARY-FIBROSIS | EXPRESSION
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 11, pp. 1029 - 1035
Journal Article
BLOOD, ISSN 0006-4971, 11/2017, Volume 130, Issue 21, pp. 2326 - 2338
A number of studies have recently demonstrated that super-enhancers, which are large cluster of enhancers typically marked by a high level of acetylation of... 
APOPTOTIC RESPONSE | HTLV-I | SUPER-ENHANCERS | MULTICENTER PHASE-II | KINASE C-ABL | DNA-DAMAGE | LYMPHOMA | 1ST HUMAN RETROVIRUS | LEUKEMIA/LYMPHOMA | KAPPA-B | HEMATOLOGY
Journal Article
Nature Cell Biology, ISSN 1465-7392, 2014, Volume 16, Issue 4, pp. 376 - 381
Journal Article